Obesity Clinical Trial
Official title:
Body Worlds 3 - Nutrition and College of Pharmacy Weeks Exhibit and Lifestyle Intervention
Primary Aim # 1: Determine the willingness of the public to participate in an intervention
trial - NutritionQuest's Alive!TM - available in a public forum.
Aim #1 Hypotheses: Less than 10% of individuals visiting the NutritionWeek site will
register to participate in the Alive!TM Intervention; 70% of these individuals will complete
the full intervention.
Primary Aim # 2: To determine among individuals enrolled in the Alive!TM intervention,
changes in measurements of body composition from pre- to post-intervention.
Aim #2 Hypotheses: Participation in Alive!TM will result in positive changes in body
composition, including reduction of body weight, percent body fat and blood LDL and an
increase in blood HDL cholesterol.
Purposes:
1. Educate the public on the relationship between diet, weight and chronic disease
2. Collect data for future research
3. For participants of the Oregon Museum of Science and Industry (OMSI) portion of this
study, we also provide a diet assessment and optional 3-month intervention
Recruitment:
Researchers will have a display at OMSI coincidental with the Body Worlds 3 exhibit and at
local health fairs. Participants will be recruited from the attendees of the OMSI Body
Worlds 3 exhibit as well as general OMSI visitors from July through October 2007 and from
health fairs at later dates.
Subject procedures:
No identifiable information will be collected; only gender, year of birth, race and
ethnicity are collected on any participant.
Subjects under age 18 can participate in any or all of the following: a brief online,
touch-screen assessment of eating and physical activity (health screening for immediate,
printed feedback), physiologic measurements (height, weight, hip and waist circumference,
percent body fat, blood pressure).
Subjects who are age 18 and over can participate in any or all of the following: a brief
online, touch-screen assessment of eating and physical activity (health screening for
immediate, printed feedback), physiologic measurements (height, weight, hip and waist
circumference, percent body fat, blood pressure), finger prick to assess blood glucose and
lipid levels as well as DNA sample (mouthwash swish).
For participants of the OMSI portion of this study, adults may also choose to join a 3-month
online lifestyle intervention (Alive!™). Participants who enroll in the 3-month intervention
will receive 12 intervention messages over a 3-month period. Each of the messages will take
about 5 to 10 minutes to read. At the end of this 3-month period, participants will receive
a post-assessment health screening at the Oregon Health & Science University (OHSU) Clinical
and Translational Research Center. This post-assessment will include completion of a diet
and physical activity assessment, fasting blood measures of glucose and lipids, blood
pressure, weight and height.
All visitors to the display area and all research subjects will be offered educational
materials.
Instruments used, for OMSI participants only:
The Alive!TM lifestyle intervention is a web-based diet assessment program designed to help
individuals evaluate their diet and make healthy changes via tailored e-mail correspondence.
This program is operated by NutritionQuest out of Berkeley, California; utilizing the Block
questionnaires, designed and validated over many years by Dr. Gladys Block, and now in use
by researchers and health practitioners world-wide.
Data analysis:
De-identified data will be stored for future analyses and will be used in descriptive
analyses to provide information on the distribution of body size variables and how they
relate to reported dietary intake. DNA data from cheek cell samples will be linked by
identification number to dietary intake and physiologic measures. Though de-identified, this
data may still be used to identify genetic profiles of individuals with various physiologic
parameters.
For OMSI participants only:
Alive!TM lifestyle intervention data will be used to determine predictors of change in
physiologic and reported intake measures pre and post-intervention, using analysis of
variance. At the time of analyses ALL data (including Alive!TM participant data) will be
de-identified.
Status | Completed |
Enrollment | 3188 |
Est. completion date | March 2008 |
Est. primary completion date | March 2008 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - Attendees of public health fairs - General population - Under the age of 18 - Above the age of 18 Exclusion Criteria: |
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
United States | Oregon Health & Science University | Portland | Oregon |
Lead Sponsor | Collaborator |
---|---|
Oregon Health and Science University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Determine the willingness of the public to participate in an intervention trial - NutritionQuest's Alive!TM - available in a public forum. | pre-intervention | No | |
Secondary | To determine among individuals enrolled in the Alive!TM intervention, changes in measurements of body composition from pre- to post-intervention. | pre- and post-intervention | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |